Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia

Journal of Biomedical Research

Volumn 27, Issue 1, 2013, Pages 29-36

  Wang, Nuan ^a   Chen, Xianming ^c   Geng, Deqin ^b   Huang, Hongli ^a   Zhoua, Hao ^a  

^a Oriental People's Hospital of Xuzhou   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c Department of Neurology The 73087 Military Hospital   (China)

Author keywords

Apoptosis; Cognitive ability; D galactose; Dementia model; Ginkgo biloba extract; Protein kinase B (PKB)

Indexed keywords

GALACTOSE; GINKGO BILOBA EXTRACT; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CELL NUCLEUS; COGNITION; CONTROLLED STUDY; CRESYL VIOLET STAINING; CYTOPLASM; DEMENTIA; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; GINKGO BILOBA; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEARNING; LEARNING DISORDER; LOW DRUG DOSE; MEMORY; MEMORY DISORDER; MICRONUCLEUS; MORPHOLOGY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; STAINING; Y-MAZE TEST;

EID: 84885443582     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20120047     Document Type: Article

References (29)

1. Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, et al. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 2006; 84: 647-54.
2. Zhang D, Liu G, Shi J, Zhang J. Coeloglossum viride var bracteatum extract attenuates D-galactose and NaNO2 induced memory impairment in mice. J Ethnopharmacol 2006; 104(1-2): 250-6.
3. Kong WJ, Wang Y, Wang Q, Hu YJ, Han YC, Liu J. The relation between D-galactose injection and mitochondrial DNA 4834 bp deletion mutation. Exp Gerontol 2006: 41: 628-34.
4. Zhang Q, Li X, Cui X, Zuo P. D-galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res 2005; 27: 552-6.
5. DeFeudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications [J]. Curr Drug Targets 2000; 1: 25-58.
6. Ling Tang.The pharmacology and clinical application of Ginkgo biloba leaf extract. Chinese Medicine 2001; 14: 401-2.
7. Wu WR, Zhu XZ. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 1999; 65: 157-64.
8. Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr, 2010; 10: 14.
9. Wang BS, Wang H, Song YY, Qi H, Rong ZX, Zhang L, et al. Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis. Pharmacopsychiatry 2010; 43: 86-91.
10. Shah ZA, Nada SE, Doré S. Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection. Neuroscience 2011; 180: 248-55.
11. Braidy N, Jayasena T, Poljak A, Sachdev PS. Sirtuins in cognitive ageing and Alzheimer's disease. Curr Opin Psychiatry 2012; 25: 226-30.
12. Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL. Resveratrol protects rats from Aß-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One 2011; 6: e29102.
13. Brunet A, Datta SR, Greenberg ME. Transcriptiondependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001; 11: 297-305.
14. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000, 346: 561-76.
15. Wong ML, Kaye AH, Hovens CM. Tar-getingmalignant glioma survival signalling to improve clinical outcomes. Clin Neurosci 2007; 14: 301-8.
16. Zhao L, Vogt P K. Class I P I3K in onco-genic cellular transformation. Oncogene, 2008; 27: 5486-96.
17. Kong WJ, Wang Y, Wang Q, Hu YJ, Han YC, Liu J. The relation between D-galactose injection and mitochondrial DNA 4834 bp deletion mutation. Exp Gerontol 2006; 41: 628-34.
18. Christen, Y. Ginkgo biloba and neurodegenerative disorders. Front Biosci 2004; 1: 3091-104.
19. Napryeyenko O, Borzenko I. GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial. Arzneimittelforschung 2007; 57: 4-11.
20. Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res 2012; 46: 716-23.
21. Rodriguez-Martin JL, Qizilbash N, Lopez-Arrieta JM. Thiamine for Alzheimer's disease. Cochrane Database Syst Rev 2001; 2: CD001498.
22. Takuma H, Tomiyama T, Kuida K, Mori H. Amyloid beta peptide-induced cerebral neuronal loss is mediated by Caspase-3 in vivo. J Neuropathol Exp Neurol 2004; 63: 255-61.
23. Xiaoyu Chen, Bin Li. Effects of Ginkgo biloba extract on brain injury protection. Jiangsu pharmaceutical, 2009; 35: 335-7
24. Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease. Neuropsychobiology; 2002; 45: 19-26.
25. Ramassamy C, Krzywkowski P, Averill D, Lussier-Cacan S, Theroux L, ChristenY, et al. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain.Brain Res Mol Brain Res 2001; 86(1-2): 76-83.
26. Lindsten T, Zong WX, Thompson CB. Defining the role of the Bcl-2 family of proteins in the nervous system. Neuroscientist 2005; 11: 10-5.
27. Ferreiro E, Baldeiras I, Ferreira IL, Costa RO, Rego AC, Pereira CF, et al. Mitochondrialand endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers. Int J Cell Biol 2012; 735206.
28. Martín D, Salinas M, López-Valdaliso R, Serrano E, Recuero M, Cuadrado A. Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 2001; 78: 1000-8.
29. Watanabe CM, Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ, et al. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci USA 2001; 98: 6577-80.